Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update. (Record no. 10802606)

MARC details
000 -LEADER
fixed length control field 01300 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513212630.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1084-9785
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1089/cbr.1996.11.289
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nieken, J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000629
245 00 - TITLE STATEMENT
Title Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer biotherapy & radiopharmaceuticals
Date of publication, distribution, etc. Oct 1996
300 ## - PHYSICAL DESCRIPTION
Extent 289-95 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision mortality
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Subcutaneous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-2
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision mortality
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Outpatients
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sleijfer, D T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Buter, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de Leij, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mulder, N H
773 0# - HOST ITEM ENTRY
Title Cancer biotherapy & radiopharmaceuticals
Related parts vol. 11
-- no. 5
-- p. 289-95
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1089/cbr.1996.11.289">https://doi.org/10.1089/cbr.1996.11.289</a>
Public note Available from publisher's website

No items available.